{"id":29738,"date":"2023-05-12T11:35:47","date_gmt":"2023-05-12T15:35:47","guid":{"rendered":"https:\/\/joinastudy.ca\/?p=29738"},"modified":"2023-05-12T11:35:49","modified_gmt":"2023-05-12T15:35:49","slug":"fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults","status":"publish","type":"post","link":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/","title":{"rendered":"FDA Approves World\u2019s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults"},"content":{"rendered":"\n<p>The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for <a href=\"https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/us-fda-approves-gsk-s-arexvy-the-world-s-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/\" target=\"_blank\" rel=\"noreferrer noopener\">Arexvy<\/a>, the world&rsquo;s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It is responsible for up to 177,000 hospitalizations and 14,000 deaths annually in the US alone.\u00a0<\/p>\n\n\n\n<p>JoinAStudy.ca would like to highlight the efforts of our investigators <a href=\"https:\/\/joinastudy.ca\/study-locations\/london-east-medical-centre-dr-dzongowski\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Peter Dzongowski<\/a>, <a href=\"https:\/\/joinastudy.ca\/study-locations\/cook-street-medical-clinic-dr-jones\/\">Dr. Michael Jones<\/a>, <a href=\"https:\/\/joinastudy.ca\/study-locations\/broadway-medical-building-dr-lai\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. James Lai<\/a> and <a href=\"https:\/\/joinastudy.ca\/study-locations\/bluewater-clinical-research-group\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Sean Peterson<\/a> who all took part in the series of trials leading to this approval. We would also like to thank their dedicated patients and study volunteers, whose participation in Phase 3 of this study was integral in gathering the necessary data to confirm the efficacy and safety of Arexvy.\u00a0<\/p>\n\n\n\n<p>Arexvy is a single-shot vaccine that is designed to stimulate the immune system to produce antibodies against the RSV virus. It contains a protein found on the surface of the virus, which triggers an immune response from the body. The vaccine has been shown to be safe and effective in clinical trials, with a high level of protection against RSV infection and related hospitalizations.&nbsp;<\/p>\n\n\n\n<p>The approval of Arexvy is an important development in the fight against RSV. Until now, there has been no vaccine available to protect human beings against the virus. The approval of Arexvy represents a significant milestone in the development of RSV vaccines and is likely to have a major impact on the health and well-being of older adults around the world.&nbsp;<\/p>\n\n\n\n<p>The vaccine is expected to be available in the US in the coming months. GSK has also announced plans to seek approval for the vaccine in other countries, including Europe and Japan.&nbsp;<\/p>\n\n\n\n<p>In addition to its use in seniors, Arexvy is now also being studied in other populations at serious risk of complications from RSV, including infants and pregnant women. RSV is a common cause of respiratory illness in infants and young children, and there is currently no vaccine available to protect them against the virus. The development of a vaccine for this population could have a significant impact on public health, particularly in developing countries where RSV is a major cause of childhood mortality.&nbsp;<\/p>\n\n\n\n<p>Overall, the approval of Arexvy is a major step forward in the fight against RSV. With its high level of protection and potential use in multiple populations, the vaccine has the potential to save thousands of lives and prevent serious illness in millions of people around the world.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for Arexvy, the world&rsquo;s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It<\/p>\n","protected":false},"author":964,"featured_media":29739,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[487,488,489,550],"tags":[17,19,437,438,718],"class_list":["post-29738","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-drug-development","category-health-canada-fda","category-industry-news","category-study-results","tag-health-canada-fda","tag-drug-development","tag-fda","tag-drug-approval","tag-rsv","category-487","category-488","category-489","category-550","description-off"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Approves World\u2019s First Respiratory Syncytial Virus Vaccine<\/title>\n<meta name=\"description\" content=\"The US FDA has granted approval to GlaxoSmithKline for the world&#039;s first vaccine designed to protect seniors against RSV.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Approves World\u2019s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults\" \/>\n<meta property=\"og:description\" content=\"The US FDA has granted approval to GlaxoSmithKline for the world&#039;s first vaccine designed to protect seniors against RSV.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/\" \/>\n<meta property=\"og:site_name\" content=\"JoinAStudy.ca\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/joinastudy.ca\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-12T15:35:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-12T15:35:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/joinastudy.ca\/wp-content\/uploads\/50782991392_daeccae352_b.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"JoinAStudy Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:site\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"JoinAStudy Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/\"},\"author\":{\"name\":\"JoinAStudy Team\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/da824a10716e724d72676ec94d865d71\"},\"headline\":\"FDA Approves World\u2019s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults\",\"datePublished\":\"2023-05-12T15:35:47+00:00\",\"dateModified\":\"2023-05-12T15:35:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/\"},\"wordCount\":445,\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/50782991392_daeccae352_b.jpg\",\"keywords\":[\"Health Canada &amp; FDA\",\"Drug Development\",\"FDA\",\"Drug Approval\",\"RSV\"],\"articleSection\":[\"Drug Development\",\"Health Canada &amp; FDA\",\"Industry News\",\"Study Results\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/\",\"name\":\"FDA Approves World\u2019s First Respiratory Syncytial Virus Vaccine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/50782991392_daeccae352_b.jpg\",\"datePublished\":\"2023-05-12T15:35:47+00:00\",\"dateModified\":\"2023-05-12T15:35:49+00:00\",\"description\":\"The US FDA has granted approval to GlaxoSmithKline for the world's first vaccine designed to protect seniors against RSV.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/#primaryimage\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/50782991392_daeccae352_b.jpg\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/50782991392_daeccae352_b.jpg\",\"width\":1024,\"height\":683,\"caption\":\"Pfizer pediatric COVID vaccine EUA\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Approves World\u2019s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"name\":\"JoinAStudy.ca\",\"description\":\"JoinAStudy.ca - Help create a healthier future\",\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\",\"name\":\"JoinAStudy.ca\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"width\":118,\"height\":65,\"caption\":\"JoinAStudy.ca\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/joinastudy.ca\",\"https:\\\/\\\/x.com\\\/JoinAStudy_ca\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC_ed0XmzH5ImSNOEJcdXKqg\"],\"publishingPrinciples\":\"https:\\\/\\\/joinastudy.ca\\\/why-join-a-study\\\/\",\"ownershipFundingInfo\":\"https:\\\/\\\/joinastudy.ca\\\/information-disclaimer\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/da824a10716e724d72676ec94d865d71\",\"name\":\"JoinAStudy Team\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/author\\\/grant\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Approves World\u2019s First Respiratory Syncytial Virus Vaccine","description":"The US FDA has granted approval to GlaxoSmithKline for the world's first vaccine designed to protect seniors against RSV.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/","og_locale":"fr_FR","og_type":"article","og_title":"FDA Approves World\u2019s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults","og_description":"The US FDA has granted approval to GlaxoSmithKline for the world's first vaccine designed to protect seniors against RSV.","og_url":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/","og_site_name":"JoinAStudy.ca","article_publisher":"https:\/\/www.facebook.com\/joinastudy.ca","article_published_time":"2023-05-12T15:35:47+00:00","article_modified_time":"2023-05-12T15:35:49+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/50782991392_daeccae352_b.jpg","type":"image\/jpeg"}],"author":"JoinAStudy Team","twitter_card":"summary_large_image","twitter_creator":"@JoinAStudy_ca","twitter_site":"@JoinAStudy_ca","twitter_misc":{"\u00c9crit par":"JoinAStudy Team","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/#article","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/"},"author":{"name":"JoinAStudy Team","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/da824a10716e724d72676ec94d865d71"},"headline":"FDA Approves World\u2019s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults","datePublished":"2023-05-12T15:35:47+00:00","dateModified":"2023-05-12T15:35:49+00:00","mainEntityOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/"},"wordCount":445,"publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/50782991392_daeccae352_b.jpg","keywords":["Health Canada &amp; FDA","Drug Development","FDA","Drug Approval","RSV"],"articleSection":["Drug Development","Health Canada &amp; FDA","Industry News","Study Results"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/","url":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/","name":"FDA Approves World\u2019s First Respiratory Syncytial Virus Vaccine","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/#primaryimage"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/50782991392_daeccae352_b.jpg","datePublished":"2023-05-12T15:35:47+00:00","dateModified":"2023-05-12T15:35:49+00:00","description":"The US FDA has granted approval to GlaxoSmithKline for the world's first vaccine designed to protect seniors against RSV.","breadcrumb":{"@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/#primaryimage","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/50782991392_daeccae352_b.jpg","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/50782991392_daeccae352_b.jpg","width":1024,"height":683,"caption":"Pfizer pediatric COVID vaccine EUA"},{"@type":"BreadcrumbList","@id":"https:\/\/joinastudy.ca\/fr\/fda-approves-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/joinastudy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"FDA Approves World\u2019s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults"}]},{"@type":"WebSite","@id":"https:\/\/joinastudy.ca\/fr\/#website","url":"https:\/\/joinastudy.ca\/fr\/","name":"JoinAStudy.ca","description":"JoinAStudy.ca - Help create a healthier future","publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/joinastudy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/joinastudy.ca\/fr\/#organization","name":"JoinAStudy.ca","url":"https:\/\/joinastudy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","width":118,"height":65,"caption":"JoinAStudy.ca"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/joinastudy.ca","https:\/\/x.com\/JoinAStudy_ca","https:\/\/www.youtube.com\/channel\/UC_ed0XmzH5ImSNOEJcdXKqg"],"publishingPrinciples":"https:\/\/joinastudy.ca\/why-join-a-study\/","ownershipFundingInfo":"https:\/\/joinastudy.ca\/information-disclaimer\/"},{"@type":"Person","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/da824a10716e724d72676ec94d865d71","name":"JoinAStudy Team","url":"https:\/\/joinastudy.ca\/fr\/author\/grant\/"}]}},"_links":{"self":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/29738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/users\/964"}],"replies":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/comments?post=29738"}],"version-history":[{"count":0,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/29738\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media\/29739"}],"wp:attachment":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media?parent=29738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/categories?post=29738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/tags?post=29738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}